Internal Medicine, Pulmonary Disease · Milwaukee, WI
NPI
1821040494
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
9200 W Wisconsin Ave, Pulmonary Disease
Milwaukee, WI, 53226
Phone (414) 805-6633
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
781 services
Medicare patients, 2024
422
Average age 70
Drug cost, 2024
$2.9M
2,746 prescriptions
Company payments, 2025
$312
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rose A Franco was code 99214 (office e&m - established), 186 times for 145 patients. In total Rose A Franco billed 781 services in 34 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 186 | 145 | $65.67 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 148 | 125 | $12.23 | $1,810 |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 74 | 73 | $32.32 | $2,391 |
| 99215 Office E&M - Established | Facility | 64 | 51 | $96.95 | $6,205 |
| 99213 Office E&M - Established | Facility | 52 | 49 | $42.22 | $2,195 |
| 99204 Office E&M - New | Facility | 49 | 49 | $81.70 | $4,003 |
| 95811 Sleep Study | Facility | 46 | 44 | $87.64 | $4,031 |
| 99232 Hospital E&M - Subsequent | Facility | 37 | 24 | $54.13 | $2,003 |
| 99203 Office E&M - New | Facility | 32 | 32 | $54.88 | $1,756 |
| 99222 Hospital E&M - Initial | Facility | 23 | 22 | $91.64 | $2,108 |
By year: 2022 $58K for 730 services; 2023 $50K for 667 services; 2024 $44K for 781 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rose A Franco prescribed most often to Medicare patients was Montelukast Sodium, with 255 prescriptions and refills. In total Rose A Franco wrote 2,746 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 255 | 602 | 85 | $2,867 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 253 | 381 | 96 | $10K |
| Azithromycin Generic | 174 | 268 | 57 | $2,723 |
| Prednisone Generic | 170 | 187 | 81 | $649 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 108 | 176 | 23 | $112K |
| Gabapentin Generic | 91 | 127 | 23 | $1,373 |
| Zolpidem Tartrate Generic | 86 | 94 | 16 | $513 |
| Symbicort Budesonide/Formoterol Fumarate | 85 | 157 | 26 | $36K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 74 | 164 | 29 | $18K |
| Breo Ellipta Fluticasone/Vilanterol | 64 | 84 | 13 | $34K |
| Fluticasone Propionate Generic | 61 | 137 | 18 | $1,283 |
| Dupixent Pen Dupilumab | 48 | 48 | Under 11 | $173K |
| Ventolin Hfa Albuterol Sulfate | 47 | 73 | 19 | $4,571 |
| Incruse Ellipta Umeclidinium Bromide | 46 | 62 | 11 | $22K |
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 44 | 44 | Under 11 | $1.2M |
Brand drugs: - claims; generic drugs: 1,560 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rose A Franco $312 ($312 in general payments such as food, travel and fees) from 7 companies. The largest payer was Viatris Specialty LLC with $120.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.